- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02830867
Review of French Cases of Glutathione Synthetase Deficiency
January 8, 2018 updated by: University Hospital, Strasbourg, France
The glutathione synthetase deficiency, inborn error of metabolism of autosomal recessive inheritance, is a rare disease (70 patients described in the world).
The outcome of these patients and potential complications of this disease are not, to date, yet all known and described.
Study Overview
Status
Unknown
Conditions
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Didier EYER, MD
- Phone Number: 33 (0)3.88.12.81.18
- Email: didier.eyer@chru-strasbourg.fr
Study Contact Backup
- Name: Claire BANSEPT
- Phone Number: 33 (0)3.88.12.77.57
- Email: claire.bansept@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service D'Urgences Medicales Pediatriques
-
Contact:
- Didier EYER, MD
- Email: didier.eyer@chru-strasbourg.fr
-
Contact:
- Claire BANSEPT, MD
- Email: cbansept@hotmail.com
-
Principal Investigator:
- Didier EYER, MD
-
Sub-Investigator:
- Claire BANSEPT, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
All patients followed in the French hospital centers the diagnosis of glutathione synthetase deficiency has been proven by assay of residual enzyme activity or identifying a mutation of the glutathione synthetase gene
Description
Inclusion criteria:
- All patients followed in the French hospital centers the diagnosis of glutathione synthetase deficiency has been proven by assay of residual enzyme activity or identifying a mutation of the glutathione synthetase gene
Exclusion criteria:
- No formal proof of glutathione synthetase deficiency
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Immunologically determining human acid glutathione S-transferase in a human assay sample
Time Frame: 1 hour after hospitalization
|
1 hour after hospitalization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2016
Primary Completion (Anticipated)
October 1, 2018
Study Completion (Anticipated)
October 1, 2018
Study Registration Dates
First Submitted
June 17, 2016
First Submitted That Met QC Criteria
July 8, 2016
First Posted (Estimate)
July 13, 2016
Study Record Updates
Last Update Posted (Actual)
January 10, 2018
Last Update Submitted That Met QC Criteria
January 8, 2018
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 6245
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on The Glutathione Synthetase Deficiency
-
The First Hospital of Jilin UniversityNational Natural Science Foundation of ChinaUnknownGenetic Diseases, Inborn | Asparagine Synthetase DeficiencyChina
-
Baylor College of MedicineCompletedMuscle Weakness | Aging | Erythrocyte Glutathione DeficiencyUnited States
-
All India Institute of Medical Sciences, BhubaneswarNot yet recruitingThe Goal of This Trial is to to Compare the Effect of Risperidone vs Aripiprazole in Terms of Change in Serum Glutathione Level
-
Baylor College of MedicineCompletedHIV Infection | Erythrocyte Glutathione DeficiencyUnited States
-
Baylor College of MedicineCompletedHIV Infection | Erythrocyte Glutathione DeficiencyUnited States
-
Galderma R&DCompletedVolume Deficiency of the MidfaceGermany, Italy, United Kingdom
-
Neon HospitalCompletedEffects of the External Testosteron Intake Over the Choroids of the Patients With Androgen DeficiencyTurkey
-
Baylor College of MedicineChildren's National Research InstituteRecruitingOrnithine Transcarbamylase Deficiency | Urea Cycle Disorder | Carbamyl Phosphate Synthetase Deficiency | Argininosuccinic Aciduria | Hyperargininemia | Citrullinemia 1 | ARGI Deficiency | ASL Deficiency | ASS Deficiency | NAGS DeficiencyUnited States
-
Biopolimeri Srl1MedRecruitingDermal Filler | Volume Deficiency of the MidfaceItaly
-
Cytonet GmbH & Co. KGCompletedOrnithine Transcarbamylase Deficiency | Urea Cycle Disorders | Citrullinemia | Carbamoylphosphate Synthetase I DeficiencyGermany